Cormorant Asset Management

• Aspen Neuroscience

  Series C, Nov 20, 2025

• Oruka Therapeutics

  Private placement, Sep 17, 2025

• AltruBio

  Series B, May 21, 2024

• BioAge Labs

  Series D, $18M, Feb 13, 2024

• Prime Medicine

  Jul 13, 2021

• Umoja Biopharma

  Series B, Lead, Jun 15, 2021

• Biomea Fusion

  Series A, Lead, Jan 8, 2021

• Atea Pharmaceuticals

  Series D-1, Oct 1, 2020

• Monte Rosa Therapeutics

  Series B, Sep 25, 2020

• Olema Pharmaceuticals

  Series C, $8M, Sep 1, 2020

• Praxis Precision Medicines

  Series C, Jul 28, 2020

• Olema Pharmaceuticals

  Series B, $10M, Mar 1, 2020

• Principia Biopharma

  Series C, $16M, Aug 1, 2018

• Eidos Therapeutics

  Series B, Apr 5, 2018

Sources: prnewswire.com, globenewswire.com, sec.gov, lw.com, startupticker.ch, biospace.com